home / stock / bio / bio news


BIO News and Press, Bio-Rad Laboratories Inc. Class A From 10/25/22

Stock Information

Company Name: Bio-Rad Laboratories Inc. Class A
Stock Symbol: BIO
Market: NYSE
Website: bio-rad.com

Menu

BIO BIO Quote BIO Short BIO News BIO Articles BIO Message Board
Get BIO Alerts

News, Short Squeeze, Breakout and More Instantly...

BIO - Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper

Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper SYDNEY, AU, Oct 25, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the latest China biotech landscape analysis with expert gui...

BIO - Olympus Announces Leadership Succession Plan

Olympus Announces Leadership Succession Plan TOKYO, Oct 21, 2022 - (ACN Newswire) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, today announced that Stefan Kaufmann, the current Director, Exec...

BIO - AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program

AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program BRISBANE, AUS, Oct 18, 2022 - (ACN Newswire) - AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital P...

BIO - Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the third quarter of 2022 on Thursday, October 27, 2022, following the close of the market. Management will discuss these res...

BIO - The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval

The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval SYDNEY, AU, Oct 17, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar for biotechs considering the clinical...

BIO - Will Bio-Rad And Qiagen Merge? I Can't See Any Logic To This Deal

Summary Rumors are circulating that life sciences / diagnostics companies Qiagen and Bio-Rad may merge. Both companies' share prices have been suffering in 2022. But would a merger stimulate them? I doubt it. Both companies' revenue growth will likely be flat in 2022 but there...

BIO - Malaysian Genomics Signs Agreement with National Institutes of Health to Explore Research Opportunities

Malaysian Genomics Signs Agreement with National Institutes of Health to Explore Research Opportunities PETALING JAYA, Malaysia, Oct 12, 2022 - (ACN Newswire) - MGRC Therapeutics Sdn Bhd (MGRC-T), a wholly-owned subsidiary of Malaysian Genomics Resource Centre Berhad (Bursa: M...

BIO - Novotech India Recognised as "Best Workplaces for Women 2022" by Global Work Standards Authority

Novotech India Recognised as "Best Workplaces for Women 2022" by Global Work Standards Authority SYDNEY, AU, Oct 12, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, has again received "Best Workplace" certification by the leading workplace cu...

BIO - Olympus EU-ME3 Ultrasound Processor Delivers Higher Resolution Images for Endoscopic Ultrasound

Olympus EU-ME3 Ultrasound Processor Delivers Higher Resolution Images for Endoscopic Ultrasound TOKYO & HAMBURG, Oct 7, 2022 - (JCN Newswire) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, ...

BIO - Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO

Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO SYDNEY, AU, Oct 7, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, joins a prestigious group of global CROs as a finalist in the Scrip Award for Best Full-Service CRO. This ...

Previous 10 Next 10